Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • Trump promises action...

    Trump promises action on drug prices that may impact India

    Written by Ruby Khatun Khatun Published On 2017-10-21T09:30:29+05:30  |  Updated On 21 Oct 2017 9:30 AM IST
    Trump promises action on drug prices that may impact India

    Washington: US President Donald Trump has promised to bring the cost of prescription drugs way down and let other countries pay more for these medicines in a new policy that could have implications for India.


    He told his Cabinet members at a meeting at the White House yesterday that the prices of prescription drugs in the US have gone through the roof.


    "If you look at the same drug by the same exact company made in the same exact box and sold someplace else sometimes it's a fraction of what we pay in this country," he said.


    Trump did not mention any country, but his policy on prescription drugs, which was discussed during his Cabinet meeting could have implications for India.


    This is because for instance, early this year India's National Pharmaceutical Pricing Authority (NPPA) fixed the price of drug-eluting stents at USD 450 and bare-metal stents at USD 110.


    NPPA has said that it intends to take similar measures for other costly medical devices.


    "The world, as usual, has taken advantage of the United States. They are setting prices in other countries and we are not. The drug companies frankly are getting away with murder," Trump said in his opening remarks.


    "We want to bring prices down to whatever the other countries are paying or at least close to that," he said.


    "They (other countries) are setting such low prices that we're actually subsidizing other countries. And that's just not going to happen anymore," Trump said.


    "This has been going on for years where our people are paying so much more. I don't mean they are paying two percent more. They are paying double, triple, quadruple. They are paying so much more than it is very unfair to the United States as usual," Trump said.

    Donald TrumpDrug Eluting Stentsdrug pricesimpactIndiaNational Pharmaceutical Pricing AuthorityNPPApharma newsPrescription DrugsTrumpWhite House
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok